Status:

RECRUITING

Efficacy of Triple-daily 15mA tACS on Adolescent NSSI

Lead Sponsor:

Shanghai Mental Health Center

Conditions:

Self-Injurious Behavior

Eligibility:

All Genders

12-21 years

Phase:

NA

Brief Summary

In order to assess the clinical efficacy of triple-daily 15mA-tACS stimulation by comparing the effects of active and sham tACS interventions on driving improvements in adolescent Nonsuicidal Self-Inj...

Detailed Description

Recognizing the clinical shortcomings of traditional methods for adolescent NSSI, study objective is to establish evidence supporting the efficacy of a triple-daily 15mA-tACS stimulation regimen targe...

Eligibility Criteria

Inclusion

  • Diagnosis of NSSI based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria section 3 diagnostic criteria.
  • Five or more NSSI episodes in the past year and at least one NSSI episode in the past month.
  • Age between 12 and 21 years.
  • Informed consent from parents or legal guardians.
  • Informed consent from participants aged 15 years and above.

Exclusion

  • Current or history of organic brain disorders or neurological disorders.
  • Elevated or imminent suicidal risk, as assessed by clinicians during routine screening.
  • Previous or current exposure to electroconvulsive therapy (ECT), modified ECT, TMS, transcranial direct current stimulation (tDCS), tACS, or other neurostimulation treatments.
  • Presence of cochlear implants, cardiac pacemakers, implanted devices, or metal in the brain.
  • Previous or current use of psychotropic medication.
  • Pregnancy or lactation.
  • Participation in another concurrent clinical trial.
  • Refusal to provide informed consent to participate in the trial.
  • Other circumstances deemed unsuitable for participation by researchers.

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2027

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT06919432

Start Date

May 1 2025

End Date

September 30 2027

Last Update

June 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China, 200030

Efficacy of Triple-daily 15mA tACS on Adolescent NSSI | DecenTrialz